Adjuvant treatment of melanoma using placebo or no therapies as control-arm: is it ethically correct?

Five-year survival with tebentafusp in metastatic uveal melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

The role of the molecular tumor board: learnings from the ROME trial.

NPJ precision oncology·2026

Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Comprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma.

Melanoma research·2026

Comprehensive role of fluorine-18-labeled fluorodeoxyglucose PET/computed tomography across the disease course of primary malignant melanoma of the esophagus.

Melanoma research·2026

Dissociation between systemic inflammatory markers and the tumor microenvironment in predicting sentinel lymph node metastasis in cutaneous melanoma.

Melanoma research·2026

Association between perioperative antidepressant use and postoperative outcomes after cutaneous melanoma resection.

Melanoma research·2026

Transcriptomic immune subtyping and connectivity mapping nominate DNA methyltransferase inhibitors for immunedepleted melanoma.

Melanoma research·2026

DPM2 promotes melanoma progression and serves as a prognostic factor.

Melanoma research·2026

Global Underutilization of Antiviral Therapy and Survival Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of 78 Studies and 68,243 Patients.

Journal of viral hepatitis·2026

Perceptions of Medical Assistance in Dying in Head and Neck Oncology in Canada: A National Survey Study.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2026

First-line fluoropyrimidine- versus gemcitabine-based chemotherapy for metastatic recurrence after resection of ampullary adenocarcinoma: A real-world analysis of the FFCD-AC cohort.

European journal of cancer (Oxford, England : 1990)·2026

Minoxidil and Prostaglandin Analogs for Chemotherapy-Induced Alopecia: A Scoping Review.

Current oncology reports·2026

Gut microbiota-considered pharmacotherapeutic management of hepatocellular carcinoma.

Expert opinion on pharmacotherapy·2026

Evolving Molecular Drug Targets in Pancreatic Cancer: An Updated Review.

Current cancer drug targets·2026

Related Experiment Videos

Adjuvant treatment of melanoma using placebo or no therapies as control-arm: is it ethically correct?

Related Concept Videos

Five-year survival with tebentafusp in metastatic uveal melanoma.

IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.

The role of the molecular tumor board: learnings from the ROME trial.

Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.

Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Comprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma.

Comprehensive role of fluorine-18-labeled fluorodeoxyglucose PET/computed tomography across the disease course of primary malignant melanoma of the esophagus.

Dissociation between systemic inflammatory markers and the tumor microenvironment in predicting sentinel lymph node metastasis in cutaneous melanoma.

Association between perioperative antidepressant use and postoperative outcomes after cutaneous melanoma resection.

Transcriptomic immune subtyping and connectivity mapping nominate DNA methyltransferase inhibitors for immunedepleted melanoma.

DPM2 promotes melanoma progression and serves as a prognostic factor.

Global Underutilization of Antiviral Therapy and Survival Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of 78 Studies and 68,243 Patients.

Perceptions of Medical Assistance in Dying in Head and Neck Oncology in Canada: A National Survey Study.

First-line fluoropyrimidine- versus gemcitabine-based chemotherapy for metastatic recurrence after resection of ampullary adenocarcinoma: A real-world analysis of the FFCD-AC cohort.

Minoxidil and Prostaglandin Analogs for Chemotherapy-Induced Alopecia: A Scoping Review.

Gut microbiota-considered pharmacotherapeutic management of hepatocellular carcinoma.

Evolving Molecular Drug Targets in Pancreatic Cancer: An Updated Review.

Related Experiment Videos

Adjuvant treatment of melanoma using placebo or no therapies as control-arm: is it ethically correct?

Related Concept Videos

Related Articles